Aurora Cannabis (ACB) Retained Earnings (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Retained Earnings of -$4.7 billion for Q1 2026, down 4340.03% year-over-year from $110.8 million in Q1 2025, and down 2.28% quarter-over-quarter from -$4.6 billion in Q4 2025.
Aurora Cannabis (ACB) Retained Earnings (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Retained Earnings for 9 consecutive years, with -$4.7 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 4340.03% year-over-year to -$4.7 billion; the TTM figure through Mar 2026 stood at -$4.7 billion (down 4340.03% YoY), while the FY2026 annual figure was -$4.7 billion, down 4207.75% from the prior year.
- Retained Earnings retreated to -$4.7 billion in Q1 2026 per ACB's latest filing, from -$4.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at $120.5 million in Q1 2024 and bottomed at -$4.7 billion in Q2 2022.
- Historically, Retained Earnings has averaged -$4.1 billion across 5 years, with a median of -$4.7 billion in 2025.
- Annual changes were most pronounced in 2024 — Retained Earnings surged 102.59% — and 2026, when it tumbled 4340.03%.
- Aurora Cannabis' Retained Earnings stood at -$4.6 billion in 2022, then declined by 2.13% to -$4.7 billion in 2023, then grew by 2.69% to -$4.6 billion in 2024, then decreased by 0.9% to -$4.6 billion in 2025, then fell by 2.28% to -$4.7 billion in 2026.
- Business Quant data shows ACB's Retained Earnings at -$4.7 billion in Q1 2026, -$4.6 billion in Q4 2025, and -$4.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | Aurora Cannabis | 232.22 Mn | 159.91 Mn | 25.75 Mn | -4.66 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.70 Bn |
| Dec 31, 2025 | -4.59 Bn |
| Sep 30, 2025 | -4.65 Bn |
| Jun 30, 2025 | -4.61 Bn |
| Mar 31, 2025 | 110.79 Mn |
| Dec 31, 2024 | -4.55 Bn |
| Sep 30, 2024 | -4.68 Bn |
| Jun 30, 2024 | -4.66 Bn |
| Mar 31, 2024 | 120.48 Mn |
| Dec 31, 2023 | -4.68 Bn |
| Sep 30, 2023 | -4.73 Bn |
| Jun 30, 2023 | -4.71 Bn |
| Mar 31, 2023 | -4.65 Bn |
| Dec 31, 2022 | -4.58 Bn |
| Sep 30, 2022 | -4.72 Bn |
| Jun 30, 2022 | -4.73 Bn |
| Mar 31, 2022 | -4.28 Bn |
| Dec 31, 2021 | -3.50 Bn |
| Sep 30, 2021 | -3.44 Bn |
| Jun 30, 2021 | 115.11 Mn |